Karen Dengel
- Oncology top 5%
- Molecular Biology
- Immunology top 10%
- Biomedical Engineering
- Hematology top 10%
- Co-authors
- Edward A. StadtmauerSimon F. LaceyCarl H. JuneJ. Joseph MelenhorstBruce L. LevineDan T. VoglAdam D. CohenAlfred L. Garfall
- Topics
- CAR-T cell therapy research (7 papers)Immunotherapy and Immune Responses (2 papers)Cancer Immunotherapy and Biomarkers (2 papers)
- Cited by
- OncologyHematologyImmunology
- Partner nations
- United States
In The Last Decade
Karen Dengel
8 papers receiving 609 citations
Hit Papers
Peers
Comparison fields: 5 of 37
- Oncology 547
- Molecular Biology 245
- Immunology 226
- Biomedical Engineering 139
- Hematology 137
Countries citing papers authored by Karen Dengel
This map shows the geographic impact of Karen Dengel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Dengel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Dengel more than expected).
Fields of papers citing papers by Karen Dengel
This network shows the impact of papers produced by Karen Dengel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Dengel. The network helps show where Karen Dengel may publish in the future.
Co-authorship network of co-authors of Karen Dengel
This figure shows the co-authorship network connecting the top 25 collaborators of Karen Dengel. A scholar is included among the top collaborators of Karen Dengel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen Dengel. Karen Dengel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 20 | |
| 3 | 69 | |
| 4 | 10 | |
| 5 | 25 | |
| 6 | 36 | |
| 7 | Chimeric Antigen Receptor T Cells against CD19 for Multiple Myelomabreakdown → | 434 |
| 8 | 8 |
About Karen Dengel
Karen Dengel is a scholar working on Oncology, Genetics and Immunology, having authored 8 papers that have together received 616 indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Oncology (547 citations), Hematology (137 citations) and Immunology (226 citations). Karen Dengel has collaborated with scholars based in United States. Frequent co-authors include Edward A. Stadtmauer, Simon F. Lacey, Carl H. June, J. Joseph Melenhorst, Bruce L. Levine, Dan T. Vogl, Adam D. Cohen, Alfred L. Garfall, Brendan M. Weiss and Wei‐Ting Hwang. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.